---
schema_version: "secwatch.filing_event.v1"
accession: "0001999371-26-005742"
form_type: "8-K"
ticker: "TNXP"
cik: "0001430306"
company_name: "Tonix Pharmaceuticals Holding Corp."
filed_at: "2026-03-13T23:59:59+00:00"
generated_at: "2026-05-15T12:28:36.212217+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tonix reports Q4 2025 net loss $46.9M; TONMYA launch shows ~4,200 prescriptions

## Summary
- Net loss available to common stockholders for Q4 2025 was $46.9M ($3.98/share) vs $22.1M ($9.77/share) in Q4 2024.
- Full year 2025 net product revenue $13.1M, including TONMYA launch from Nov 17–Dec 31: $1.4M.
- TONMYA launch-to-date (Nov 17,2025–Feb 27,2026): >1,500 HCPs prescribed, ~2,500 patients initiated, ~4,200 cumulative prescriptions.
- Cash and equivalents $207.6M as of Dec 31, 2025 (up from $98.8M); subsequent ATM raised $8.6M.
- Cash runway expected into Q1 2027; shares outstanding 13.4M as of March 11, 2026.

## SEC filing metadata
- accession: 0001999371-26-005742
- form_type: 8-K
- ticker: TNXP
- cik: 0001430306
- company_name: Tonix Pharmaceuticals Holding Corp.
- filed_at: 2026-03-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1430306/000199937126005742/0001999371-26-005742-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1430306/000199937126005742/tonix-8k_031326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999371-26-005742
- JSON: https://secwatch.observer/filing/0001999371-26-005742.json
- Plain text: https://secwatch.observer/filing/0001999371-26-005742.txt

## Key facts
- Earnings Releases
  Tonix Pharmaceuticals Holding Corp. reported financial results for the fourth quarter and full year ended December 31, 2025.
  - Period: the fourth quarter and full year ended December 31, 2025
  - Result: reported results
  source text: announced its operating results for the quarter and year ended December 31, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1430306/000199937126005742/0001999371-26-005742-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.